Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Catalyst Grant: Infection & Immunity-PHAC/CAID/Hep C Res-Psycho/Behav/Epid

University of Ottawa

$65,350.00

Liver transplant outcomes for HIV/HCV co-infected patients: A guideline development for Canada.

FY 2009-10

Summary
Liver transplantation is a life saving procedure. Advances in new medicines and in the dosing of these medicines have improved outcomes for transplant patients. However, because of possible drug toxicity and little-known efficacy, patients that have a co-infection with HIV and hepatitis C are rarely offered transplants. We aim to determine the evidence for clinical effectiveness and complications from transplants in co-infected individuals as determined by survival, HIV disease progression and developments of cancer. Our study will be a large scale data synthesis of cohort studies in order to determine rates of death, AIDS and cancers at 1, 3 and 4 years post-transplant.
Program
Catalyst Grant: Infection & Immunity-PHAC/CAID/Hep C Res-Psycho/Behav/Epid
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
198515
Name
Mills Edward J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Clinical
Prcname2
Catalyst Grant: Infection and Immunity
Projecttitle
Liver transplant outcomes for HIV/HCV co-infected patients: A guideline development for Canada.
Programtype2
Operating Grants
Orgnameinp2
University of Ottawa
Cihramount2
$65,350
Cihrequipment2
$0
Programname2
Catalyst Grant: Infection & Immunity-PHAC/CAID/Hep C Res-Psycho/Behav/Epid
Keyworddelim
Hepatitis C; Hiv/Aids; Transplant
Abstract
Liver transplantation is a life saving procedure. Advances in new medicines and in the dosing of these medicines have improved outcomes for transplant patients. However, because of possible drug toxicity and little-known efficacy, patients that have a co-infection with HIV and hepatitis C are rarely offered transplants. We aim to determine the evidence for clinical effectiveness and complications from transplants in co-infected individuals as determined by survival, HIV disease progression and developments of cancer. Our study will be a large scale data synthesis of cohort studies in order to determine rates of death, AIDS and cancers at 1, 3 and 4 years post-transplant.
Competitiondate
200909
Approvedterm2
1 yr 0 mth
Pinamesdelim
Mills, Edward J
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $65,350~ $0~
University of Ottawa - $65,350 Grant (2009-10) | Canada Spends